β-Defensins (HBD) are involved in immune response to HPV infection in pregnancy.
Risk of HPV DNA transmission to amniotic membrane depends on delivery mode.
Down-regulated expression of HBD-2 may affect high-risk HPV-related cancerogenesis.
Therapeutic potential of HBD-2 for high-risk HPV infection should be considered.